Zhejiang Int'l Group Co

Zhejiang Int'l Group Co Days Payable Outstanding

The Days Payable Outstanding (DPO) of Zhejiang Int'l Group Co (000411.SZ) as of Nov 4, 2026 is 70.35. In the previous year, Days Payable Outstanding (DPO) was 65.95 — a change of 6.67% (higher).

Days Payable Outstanding

70.35

YoY

6.67%

Last updated:

Days Payable Outstanding (DPO) of Zhejiang Int'l Group Co is 2025 70.35 . Days Payable Outstanding (DPO) of Zhejiang Int'l Group Co was 2024 65.95 . It decreases by 6.67% higher compared to the previous year.

The Zhejiang Int'l Group Co Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2018
62.01 CNY
Jan 1, 2019
72.61 CNY
Jan 1, 2020
68.12 CNY
Jan 1, 2021
53.11 CNY
Jan 1, 2022
67.35 CNY
Jan 1, 2023
67.73 CNY
Jan 1, 2024
65.95 CNY
Jan 1, 2025
70.35 CNY
The Zhejiang Int'l Group Co Days Payable Outstanding history
YEARDays Payable OutstandingYoY
70.35+6.67%
65.95-2.62%
67.73+0.56%
67.35+26.81%
53.11-22.03%
68.12-6.19%
72.61+17.11%
62.01-27.34%
85.34+7.63%
79.29+1.48%
78.13+6.29%
73.51—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zhejiang Int'l Group Co Stock analysis

What does Zhejiang Int'l Group Co do? Zhejiang Int'l Group Co., Ltd. generates revenue by wholesaling and retailing pharmaceuticals and medical devices. The company buys products from pharmaceutical manufacturers or suppliers and distributes them to distributors, medical institutions, and pharmacies. It also sells directly to consumers through retail terminals. The firm operates exclusively within Mainland China, serving a broad customer base across the healthcare sector. The business model relies on purchasing products from manufacturers or suppliers, then reselling them through wholesale channels to medical institutions and pharmacies, or via retail terminals to end consumers. This dual-channel approach allows the company to reach both institutional and individual customers without direct manufacturing involvement. Mainland China represents the sole market for all its operations. Zhejiang Int'l Group Co., Ltd. focuses on pharmaceutical and medical device distribution, targeting distributors, medical institutions, and pharmacies as key wholesale clients. Retail sales are directed toward consumers through its own retail terminals. The company does not engage in manufacturing, instead acting as a middleman between producers and end users within the Chinese healthcare market. Zhejiang Int'l Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zhejiang Int'l Group Co stock

Days Payable Outstanding (DPO) of Zhejiang Int'l Group Co is 70.35 in 2025.

Days Payable Outstanding (DPO) of Zhejiang Int'l Group Co changed from 65.95 to 70.35, representing a 6.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Zhejiang Int'l Group Co since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Zhejiang Int'l Group Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Zhejiang Int'l Group Co

All Key Metrics — Zhejiang Int'l Group Co